Neil Graff-Radford

Rate of progression differs in frontotemporal dementia and Alzheimer disease

C. DeCarli, W. Jagust, D. Salmon, 2005, Neurology.

Plasma amyloid β protein is elevated in late-onset Alzheimer disease families

S. Younkin, L. Younkin, M. Hutton, 2008, Neurology.

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

R. Petersen, B. Boeve, T. Ferman, 2015, European journal of neurology.

Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes

Eric M. Reiman, Stephen N. Thibodeau, Anne Uecker, 1999, Neurology.

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

T. Ferman, M. Barcikowska, R. Uitti, 2015, European journal of neurology.

Family history of dementia is a risk factor for Lewy body disease

T. Ferman, D. Dickson, Z. Arvanitakis, 2006, Neurology.

Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis–frontotemporal dementia phenotypes

J. Hardy, A. Goate, R. Caselli, 2006, Journal of Neurology, Neurosurgery & Psychiatry.